0001179110-22-000112.txt : 20220104 0001179110-22-000112.hdr.sgml : 20220104 20220104162315 ACCESSION NUMBER: 0001179110-22-000112 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220103 FILED AS OF DATE: 20220104 DATE AS OF CHANGE: 20220104 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: MULLEN JAMES C CENTRAL INDEX KEY: 0001226288 STATE OF INCORPORATION: MA FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37687 FILM NUMBER: 22506339 MAIL ADDRESS: STREET 1: 940 WINTER STREET STREET 2: PERKINELMER, INC LEGAL DEPARTMENT CITY: WALTHAM STATE: MA ZIP: 02451 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Editas Medicine, Inc. CENTRAL INDEX KEY: 0001650664 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 464097528 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 11 HURLEY ST. CITY: CAMBRIDGE STATE: MA ZIP: 02141 BUSINESS PHONE: 617-401-9000 MAIL ADDRESS: STREET 1: 11 HURLEY ST. CITY: CAMBRIDGE STATE: MA ZIP: 02141 4 1 edgar.xml FORM 4 - X0306 4 2022-01-03 0 0001650664 Editas Medicine, Inc. EDIT 0001226288 MULLEN JAMES C C/O EDITAS MEDICINE, INC., 11 HURLEY ST. CAMBRIDGE MA 02141 1 1 0 0 CEO Common Stock 2022-01-03 4 S 0 18252 26.9548 D 75898 D Sale was effected pursuant to a durable automatic sales instruction plan adopted by the Reporting Person on March 4, 2021, and represents the sale of shares by the Issuer necessary to meet tax withholding obligations as a result of vesting in restricted stock units on December 22, 2021. The sale does not represent a discretionary trade by the Reporting Person. /s/ James C. Mullen 2022-01-04